We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Hikma Pharmaceuticals Plc | LSE:HIK | London | Ordinary Share | GB00B0LCW083 | ORD SHS 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
18.00 | 0.93% | 1,953.00 | 1,951.00 | 1,952.00 | 1,959.00 | 1,919.00 | 1,932.00 | 801,595 | 16:35:05 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 2.88B | 192M | 0.8653 | 22.56 | 4.29B |
Date | Subject | Author | Discuss |
---|---|---|---|
14/3/2018 07:41 | What will happen today after these results ? | gerrym two | |
12/3/2018 16:42 | Certainly could have been worse today - the drop was no worse than daily noise of the last few weeks. Hopefully they can come up with a decent set of results, and paint a rosy picture going forward | nav_mike | |
12/3/2018 09:33 | Share price reaction could have been worse. No point in selling at the bottom, if indeed it should prove so. | broadwood | |
12/3/2018 08:37 | 2 year delay | r ball | |
12/3/2018 08:31 | This is old news. Just new detail. At least now we know where we are with the FDA. New trial will/should produce the expected results. Bit disappointed it's going to take so long though. As said above, fingers crossed for a decent set of results. | bantam175 | |
12/3/2018 08:07 | Oh well at least if the results are half-decent on Wednesday they wont get tarnished by the news we've had today - markets will have digested the implications by then | nav_mike | |
12/3/2018 08:04 | That bid story: Copycat drug makers on alert as Germany's Stada eyes acquisition spree "Mr Albrecht was tight-lipped on a UK target but City analysts suggested that beleaguered London-listed firms Vectura and Hikma could fit the bill – two companies developing generic drugs, products with expired patents." | kamitora | |
12/3/2018 07:52 | A bid would suit me. Suet | suetballs | |
12/3/2018 07:49 | Bad news, heading South I fear. How much is in the price? It has had a spectacular fall. | broadwood | |
12/3/2018 07:34 | Jeez...perfect timing to nullify the potential bid story in the Telegraph at the weekend Ho hum | nav_mike | |
12/3/2018 07:24 | For sure that will the share price but I think it will recover quickly | sandeep67 | |
12/3/2018 07:20 | Original FDA decision upheld. Hikma to do further work with Advair possibly by early 2019. | sza2002 | |
01/3/2018 19:07 | The market ignoring Barclays on HIK - Sweet! - Do these brokers make it up as they go along? (It's a bit like listening to the Horse Racing punters!) Is there really any credibility in what they have to say? If so, why are there so many varying opinions from different brokers? Would they not all agree on a company's fundamentals and trading position and paint a similar outlook? Been trading over 25 years, I'm still not smart enough to work this one out!! :-/ HIK were tipped several times over Christmas & New Year. Is this a broker looking for discounted prices and wishing to grab a bargain? Then ramp it up from a Sell, to a Hold, to a Buy?.. ...They're all in pole position to do this after all! | nickg100 | |
01/3/2018 16:58 | Flippin eck what happened here today? Went out this morning with price at 825 after the Barclays downgrade, and come back to 871 and blue on the day... Im sure there were people trading with knowledge of the downgrade yesterday....the BOTs were absolutely relentless all day - or maybe im just too cynical...nah! | nav_mike | |
01/3/2018 09:13 | I bought in here at £20 last year thinking I got a good price ? keep the faith people I'm still hopeful | gozzy90 | |
01/3/2018 08:31 | I feel ur pain bro , my avg now about a tenner , ho hum. | death by donut | |
01/3/2018 08:23 | Remind me to thank Barclays after I topped up yesterday - another inspired purchase :) | nav_mike | |
01/3/2018 08:09 | Barclays downgrades to 800p target from 1500. What they gonna say after results? | bantam175 | |
27/2/2018 17:28 | Fingers crossed then; anything along those lines would be welcome. | fhmktg | |
27/2/2018 15:56 | We should get an update on 14th March. Last RNS said, the issue with FDA taken to complaint resolution committee, expected to deliberate in Q1. I guess the best we expect is an agreement on what needs to be done to get FDA approval. | karateboy | |
26/2/2018 12:16 | Any thoughts on the timing of news on the Advair issue? | fhmktg | |
22/2/2018 15:41 | Aaaaaaaand down . DbD :-( | death by donut | |
20/2/2018 16:36 | This may stop recent share price drops until results in March. It is always a good news to separate chairman and CEO roles from each other. | karateboy | |
20/2/2018 12:24 | The markets agree with you R Ball - I didn't see this coming! Over 100p thus far today. Great news from HIK :-D | nickg100 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions